NCT04754087 - G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2033

Conditions

Total Hip ArthroplastyDegenerative Joint Disease of HipAvascular Necrosis of HipRheumatoid Arthritis of HipOsteoarthritis, HipOsteoarthritis of HipFractures, HipFracture of Hip

Interventions

DEVICE

Vivacit-E and Longevity (HXLPE) Liners

This is a dual cohort study in which 150 subjects will receive the Vivacit-E (HXLPE) Liner and 150 subjects will receive the Longevity (HXLPE) Liner.

Trial Locations (11)

2650

RECRUITING

Copenhagen University Hospital Hvidovre, Hvidovre

27703

ACTIVE_NOT_RECRUITING

Duke University Medical Center, Durham

46635

ACTIVE_NOT_RECRUITING

South Bend Orthopaedics, South Bend

80210

ACTIVE_NOT_RECRUITING

Colorado Joint Replacement, Denver

84112

ACTIVE_NOT_RECRUITING

University of Utah Health, Salt Lake City

97239

ACTIVE_NOT_RECRUITING

Oregon Health and Science University, Portland

97401

ACTIVE_NOT_RECRUITING

Slocum Center for Orthopedics & Sports Medicine, Eugene

6162 BG

ACTIVE_NOT_RECRUITING

Zuyderland Hospital, Geleen

Unknown

RECRUITING

OCON Hengelo, Hengelo

221 85

RECRUITING

Skane University Hospital, Lund

BH7 7DW

RECRUITING

The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Royal Bournemouth Hospital, Bournemouth